TScan Therapeutics
TCRX
#7495
Rank
NZ$0.46 B
Marketcap
$8.81
Share price
4.13%
Change (1 day)
16.62%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$4.72

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.81. In 2022 the company made an earnings per share (EPS) of -$4.58 a decrease over its 2021 EPS that were of -$3.63.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.723.05%
2022-$4.5826.25%
2021-$3.6399.58%
2020-$1.82